Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human DAPK1 Stable Cell Line

    [CAT#: S01YF-1123-KX210]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1097 Magic™ Human DAPK1 in Vitro Assay Human Kinase Assay

    Product Information

    Target Protein
    DAPK1
    Target Family
    Kinases/Enzyme Drug Discovery Assays and Products
    Target Protein Species
    Human
    Host Cell Type
    HCT116; CHO-K1; HEK293
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Cancer Research
    Related Diseases
    Pancreatic Ductal Adenocarcinoma and Cervical Squamous Cell Carcinoma. Among its related pathways are Programmed Cell Death and Dimerization of procaspase-8
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The human DAPK1 gene encodes the enzyme death-associated protein kinase 1. A positive modulator of gamma-interferon-induced programmed cell death is death-associated protein kinase 1. A 160-kD calmodulin-dependent serine-threonine kinase with two putative P-loop consensus sites and eight ankyrin repeats is encoded by the DAPK1 gene. It is a potential tumor suppressor. The expression of the DAPK1 gene in melanocytic cells may be controlled by MITF. When DAPK1 is depleted from patients with p53-mutant tumors, it inhibits the growth of tumor cells and their count in cellular and animal models of triple receptor-negative breast cancer. The customized DAPK1 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Barbara

    The convenience of the DAPK1 cell line has significantly streamlined my workflow. Mar 15 2022

    chat Verified Customer

    chat Carol

    The DAPK1 cell line is of superior quality, and I am confident in its reliability. Nov 20 2020

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 Validation of CRISPR/Cas9-mediated DAPK1 knockout in HCT116 colorectal cancer cells.

    Using Western blot, the basal level of DAPK1 protein in the HCT116 cell line was ascertained. In contrast to DLD1 and HT29, which exhibit elevated levels of DAPK1, as well as SW480, SW620, and SW837, where no detectable DAPK1 levels were found, HCT116 exhibits low to moderate amounts of DAPK1.

    Ref: Steinmann, Sara, et al. "DAPK1 loss triggers tumor invasion in colorectal tumor cells." Cell death & disease 10.12 (2019): 895.

    Pubmed: 31772156

    DOI: 10.1038/s41419-019-2122-z

    Research Highlights

    The Ca2+/calmodulin (CaM)-dependent serine/threonine protein kinase known as death-associated protein kinase 1 (DAPK1) is involved in a number of apoptotic processes, including tumor suppression and neuronal cell death.
    Wang, Shan, et al. "DAPK1 signaling pathways in stroke: from mechanisms to therapies." Molecular neurobiology 54.6 (2017): 4716-4722.
    Pubmed: 27447806   DOI: 10.1007/s12035-016-0008-y

    Thorough research will not only shed light on DAPK1's functions, but it may also lead to the development of new treatments that target the autophagy pathway in cancer in an effort to improve treatment outcomes.
    Movahhed, Parvaneh, et al. "The impact of DAPK1 and mTORC1 signaling association on autophagy in cancer." Molecular Biology Reports 49.6 (2022): 4959-4964.
    Pubmed: 35083613   DOI: 10.1007/s11033-022-07154-1

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare